Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cord Blood
Bio-Matrix Scientific Group, Inc. CEO Tells LifeNews.com: Stem Cell Treatments from Umbilical Cord Blood Among Fastest Growing Therapy for Cancer and Leukemia Patients
April 21st, 2009
Bio-Matrix Scientific Group, Inc. (BULLETIN BOARD: BMSN) announced that it is highlighted in an Adult Stem Cell Trend Report published in LifeNews.com (http://www.lifenews.com/) on April 6, 2009 that provides an analysis for stem cell treatments from umbilical cord blood as being one of the fastest growing therapy groups. According to David Koos, Chairman and CEO of BMSN, "Umbilical cord blood has been and proven to be clinically effective for conditions including cancers, leukemia, and sickle cell anemia." BMSN is a San Diego-based biotechnology research and development company focused on cord blood and peripheral adult stem cells. The company has one of the leading...
Source: Cancer Weekly (2009-04-21)
|
